Form D · Other Health Care
CorVista Health, Inc.
Washington, DC · CIK 0001831635
Offering snapshot reported Apr 14, 2023 · SEC filing
- Reported sold
- Yet to sell Offering amount: $2M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 8, 2021 | Amendment | $24,787,020 | $2,330,005vs Nov 13, 2020 | 20 | SEC filing |
| Nov 13, 2020 | Initial | $22,457,015 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-478837
Series B Preferred Stock and Convertible Equity Instruments
Source: Form D, filed Apr 14, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Don Crawford | Director, Executive |
| Nicholas Leb | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
7144 13 Th Place Nw, Suite 2200
Washington, DC, 20012-2349
Washington, DC, 20012-2349